MVA 85A

The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who Are Infected With HIV

Safety and Immunogenicity of MVA85A in Volunteers Latently Infected With TB.

Safety and Immunogenicity of MVA85A, in Healthy Volunteers in Cape Town

A Study of 2 Doses of a New TB Vaccine, MVA85A, in Healthy Volunteers Previously Vaccinated With BCG

A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both

Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines

Safety of Tuberculosis Vaccine, MVA85A, Administered by the Intramuscular Route and the Intradermal Route